NL-OMON47539已完成不适用
Cardiac Care Bridge - Cardiac Care Bridge
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Cardiac patients of 70 years and older
- •- Admitted to the departments of cardiology or cardiothoracic surgery
- •- Electively and non-electively
- •- Admission > 48 hours
- •- Hisk of functional loss according to the screening-tool for frailty of the
- •Dutch Safety Management Program (screening on ADL-functioning, fall risk,
- •malnutrition and delirium) and/or an unplanned admission in the previous six
- •- Mini-Mental Examination Score (MMSE) >= 15
排除标准
- •- Congenital heart disease
- •- Terminal illness: defined as a life expectancy of less than three months, for
- •example because of cancer or terminal heart failure.
- •-Transferred from or to a nursing home
- •-Transferred to another hospital not participating in this study
- •- Unable to communicate in Dutch
- •- Delirium as confirmed by the treating physician
研究者
相似试验
招募中
不适用
A randomized, placebo-controlled, double-blind trial of pinggan Qianyang Prescription in the treatment of hypertension with hyperactivity of Liver Yang to control the blood pressure of patients below the standardITMCTR2100005280Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai , China
已完成
不适用
MB Cardio Heart Failure RegistryI50Heart failureDRKS00016369MEDIAN Unternehmensgruppe B.V. & Co. KG810
招募中
不适用
The Chronic Heartfailure Prevention ProjectHeart failure10082206hypertensionNL-OMON37619PoZoB500
已完成
不适用
ation-wide multicenter registry for Myocardial Damage associated with immune checkpoint inhibitor administratioMyocardial Damage associated with immune checkpoint inhibitor administrationJPRN-UMIN000042923AMED300
招募中
不适用
The multicenter Cardiology Monitoring Platform (mCMP-registry)heart failurecardiovascular diseaseNL-OMON52272Medisch Universitair Ziekenhuis Maastricht40,000